BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19954072)

  • 1. [Effects of methylation status of CpG islands on results of luciferase reporter assay].
    Zhang BZ; Deng DJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):601-6. PubMed ID: 19954072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
    Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
    Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.
    Ghoshal K; Majumder S; Datta J; Motiwala T; Bai S; Sharma SM; Frankel W; Jacob ST
    J Biol Chem; 2004 Feb; 279(8):6783-93. PubMed ID: 14610093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic control of E-cadherin (CDH1) by CpG methylation in metastasising laryngeal cancer.
    Azarschab P; Stembalska A; Loncar MB; Pfister M; Sasiadek MM; Blin N
    Oncol Rep; 2003; 10(2):501-3. PubMed ID: 12579297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN; Xu CP; Han B; Ji R
    Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
    Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K
    Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on gene expression and the 5' CpG islands methylation status of E-cadherin in acute myeloid leukemia].
    Gao F; Li Y; Liu W; Lu XL; Li X; Wang PP; Liu YP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):25-7. PubMed ID: 16732935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methylation status of CDH1 gene in preoperative abdominal lavage of patients with gastric cancer and its clinical significance].
    Luo J; Wang XB; Yu QM; Zhao T; Fang RG; Wang JJ; Zheng ZG; Yu JL; Fang XH; Wang S; Ling ZQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):710-4. PubMed ID: 22851076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis.
    Tahara T; Arisawa T; Shibata T; Nakamura M; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Takahama K; Watanabe M; Yamashita H; Hirata I
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):613-9. PubMed ID: 19307977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells.
    Nishimura M; Saito T; Yamasaki H; Kudo R
    Carcinogenesis; 2003 Oct; 24(10):1615-23. PubMed ID: 12896902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Methylation of the E-Cadherin Gene Promoter Region in Endometrium and Ovarian Endometriotic Cysts of Patients with Ovarian Endometriosis.
    Li Y; An D; Guan YX; Kang S
    Gynecol Obstet Invest; 2017; 82(1):78-85. PubMed ID: 27023436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.